Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles
Sivakumar P, Kim S, Kang HC, Shim MS. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Aug 2:e1543. PubMed
Emerging Roles for Intermolecular RNA-RNA Interactions in RNP Assemblies
Van Treeck B, Parker R. Cell. 2018 Aug 9;174(4):791-802. PubMed
The Nefarious Nexus of Noncoding RNAs in Cancer
Anastasiadou E, Faggioni A, Trivedi P, Slack FJ. Int J Mol Sci. 2018 Jul 17;19(7). PubMed
Aptamers: Uptake mechanisms and intracellular applications
Yoon S, Rossi JJ. Adv Drug Deliv Rev. 2018 Jul 6. PubMed
High-throughput determination of RNA structures
Strobel EJ, Yu AM, Lucks JB. Nat Rev Genet. 2018 Jul 27. PubMed
Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective
Vandghanooni S, Eskandani M, Barar J, Omidi Y. J Mol Med (Berl). 2018 Jul 28. PubMed
Creation of unnatural base pairs for genetic alphabet expansion toward synthetic xenobiology
Hamashima K, Kimoto M, Hirao I. Curr Opin Chem Biol. 2018 Jul 27;46:108-114. PubMed
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Springer AD, Dowdy SF. Nucleic Acid Ther. 2018 Jun;28(3):109-118. PubMed
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
Kulkarni JA, Cullis PR, van der Meel R. Nucleic Acid Ther. 2018 Jun;28(3):146-157. PubMed
Current Status of Messenger RNA Delivery Systems
Stanton MG. Nucleic Acid Ther. 2018 Jun;28(3):158-165. PubMed